Close Menu

In PLoS One this week, investigators at Harvard Medical School and elsewhere report on a microdroplet-based method they've developed to rapidly isolate viable single cells from heterogeneous solutions in order to obtain total RNA from them. The team says its method, performed on an automated platform, enables "high-throughput cell manipulation for subsequent genomic analysis" and requires "fewer handling steps compared to existing methods."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.